We report the case of a patient with tardive dystonia and a history of psychiatric illness who showed signs of neuroleptic malignant syndrome (NMS) after chronic treatment with tetrabenazine. The first symptom was a mental status change 'consisting of confusion, disorganized thinking, paranoid delus
A case of neuroleptic malignant syndrome with a history of general anesthesia
β Scribed by T. Sato; T. Hara; M. Takeichi
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 215 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
β¦ Synopsis
Antidepressant was given to treat a patient with manic-depressive psychosis, depressed type (ICD-9). Following the treatment, she manifested the alteration of the consciousness, autonomic dysfunction, extrapyramidal sign, muscular hypertonicity, hyperthermia, and elevated serum CPK levels. This condition was consistent with the neuroleptic malignant syndrome. Then, along with interruption of medication she was treated with supportive measures and improved progressively.
In her past history, she underwent general anesthesia for operation of mitral valve replacement and at that time she manifested tachycardia, hyperthermia, elevated CPK levels, etc. In the case of patients who manifest a malignant hyperthermia-like state or neuroleptic malignant syndrome-like state, special care is required in selecting anesthetics and psychotropic drugs.
π SIMILAR VOLUMES
A 67-year-old schizophrenic woman developed neuroleptic malignant syndrome (NMS). She had mild diabetes mellitus, which had been controlled with diet therapy only. Upon the onset of NMS, hyperglycemia of up to 490 mg/dl developed. The hyperglycemia persisted during the NMS episode despite insulin tr
## Abstract Neuroleptic malignantβlike syndrome (NMLS) is well described in the treatment of Parkinson's disease. The syndrome is characterized by fever, rigidity, autonomic instability, elevated creatine phosphokinase levels, and altered level of consciousness, which is usually precipitated by lev
## Abstract A schizophrenic patient receiving neuroleptic treatment developed paralytic ileus followed by the neuroleptic malignant syndrome (NMS). The patient had previously experienced two NMS episodes, one of which was also accompanied by paralytic ileus. It is suggested that paralytic ileus can
Neuroleptic malignant syndrome (NMS) is a rare and sometimes fatal adverse reaction to neuroleptic drugs. Atypical antipsychotic agents, such as risperidone, are thought to be less likely to cause N M S because of their phamacologiical profile. This is a case report of NMS associated with risperidon